Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Water/Aqua/Eau, Ethylhexyl Palmitate, Glycerin, Dimethicone, Cetearyl Alcohol, Glyceryl Stearate, Polysorbate 60, Palmitoyl Glycine, S-Palmitoylglutathione, Tetrahexyldecyl Ascorbate, PEG-100 Stearate, Ribose, Lactic Acid, Linum Usitatissimum (Linseed) Seed Oil, Macadamia Ternifolia Seed Oil, Phospholipids, Polyglyceryl-10 Stearate, Ethylhexylglycerin, Salvia Hispanica Seed Oil, Tocopherol, Helianthus Annuus (Sunflower) Seed Oil, Rosmarinus Officinalis (Rosemary) Leaf Extract, Tetrasodium Glutamate Diacetate, Sodium Hydroxide, Polyacrylamide, Sodium Acrylates Copolymer, Polysilicone-11, Hydrogenated Polyisobutene, C13-14 Isoparaffin, Laureth-7, Phenoxyethanol, Fragrance/Parfum, Citronellol, Hydroxycitronellal, Limonene, Linalool
Science 296 , 11271129 (2002) Nichols, D
BPC-157 studies using transected rat Achilles tendons report effects on tendon outgrowth, fibroblast survival under oxidative stress conditions, and dose-dependent increases in fibroblast migration
For example, in the TRANSFORMER study, patients with mCRPC who had not received prior BAT exhibited a PSA 50 response rate of 25% and median response duration of 3.8 months while on the AR inhibitor enzalutamide, while patients who had progressed on BAT exhibited a PSA 50 response rate of 78% and median duration of response of 10.9 months while on enzalutamide (9)
